Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,237,712
  • Shares Outstanding, K 141,210
  • Annual Sales, $ 729,260 K
  • Annual Income, $ -451,290 K
  • 60-Month Beta 0.94
  • Price/Sales 6.39
  • Price/Cash Flow N/A
  • Price/Book 8.07
Trade IONS with:

Options Overview Details

View History
  • Implied Volatility 65.17% ( +6.64%)
  • Historical Volatility 52.68%
  • IV Percentile 94%
  • IV Rank 59.35%
  • IV High 83.90% on 01/10/22
  • IV Low 37.81% on 04/01/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 339
  • Volume Avg (30-Day) 458
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 9,133
  • Open Int (30-Day) 7,940

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.73
  • Number of Estimates 6
  • High Estimate 1.68
  • Low Estimate 0.01
  • Prior Year -2.44
  • Growth Rate Est. (year over year) +129.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.41 +2.57%
on 01/06/22
33.09 -8.84%
on 01/14/22
-2.47 (-7.55%)
since 12/21/21
3-Month
25.04 +20.47%
on 12/02/21
35.09 -14.04%
on 11/08/21
-0.16 (-0.54%)
since 10/21/21
52-Week
25.04 +20.47%
on 12/02/21
64.37 -53.14%
on 01/26/21
-31.10 (-50.77%)
since 01/21/21

Most Recent Stories

More News
Ionis' (IONS) Partner to Begin New Huntington's Disease Study

Ionis' (IONS) partner, Roche, is planning a new phase II study to evaluate tominersen for the treatment of Huntington's disease.

NVS : 87.44 (-0.85%)
BIIB : 223.34 (-1.14%)
RHHBY : 49.3800 (-0.04%)
IONS : 30.08 (+0.23%)
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022

The analysts might be overly optimistic in some cases, though.

CRSP : 64.25 (-0.17%)
EXEL : 17.13 (+0.59%)
IONS : 30.08 (+0.23%)
AstraZeneca (AZN) Inks Deal to Develop ATTR-CM Candidate

AstraZeneca (AZN) inks collaboration and license agreement with Neurimmune AG to develop/commercialize the latter's NI006 for treating transthyretin amyloid cardiomyopathy.

AZN : 59.22 (-1.58%)
PFE : 52.83 (-2.26%)
ABBV : 132.61 (-0.32%)
IONS : 30.08 (+0.23%)
Biogen (BIIB) Opts for In-Licensing SMA Therapy From Ionis

Biogen (BIIB) exercises its option to acquire a royalty-bearing license from Ionis to develop and commercialize BIIB115/ION306 for treating spinal muscular atrophy.

NVS : 87.44 (-0.85%)
BIIB : 223.34 (-1.14%)
IONS : 30.08 (+0.23%)
DTIL : 4.62 (-7.04%)
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA

BIIB115 is a preclinical investigational antisense oligonucleotide (ASO) that may have the potential for extended dosing intervalsBiogen paid Ionis a $60...

BIIB : 223.34 (-1.14%)
IONS : 30.08 (+0.23%)
AstraZeneca (AZN) Closes Agreement for Eplontersen With Ionis

AstraZeneca (AZN) closes its agreement with Ionis for jointly developing and commercializing eplontersen in the United States.

AZN : 59.22 (-1.58%)
GSK : 45.06 (+0.40%)
ENDP : 3.29 (-0.90%)
IONS : 30.08 (+0.23%)
Ionis (IONS) Collaborates With AstraZeneca for Eplontersen

Ionis (IONS) and AstraZeneca (AZN) are set to have joint development and commercialization rights of eplontersen in the United States. AstraZeneca will have exclusive rights to commercialize it in the...

AZN : 59.22 (-1.58%)
NVS : 87.44 (-0.85%)
BIIB : 223.34 (-1.14%)
IONS : 30.08 (+0.23%)
Ionis Pharmaceuticals (IONS) Down 24.5% Since Last Earnings Report: Can It Rebound?

Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IONS : 30.08 (+0.23%)
Ionis (IONS) Q3 Earnings & Revenues Fall Short of Estimates

Ionis (IONS) incurs wider-than-expected Q3 loss. The company maintains its top-and bottom-line guidance for 2021

NVS : 87.44 (-0.85%)
BIIB : 223.34 (-1.14%)
RHHBY : 49.3800 (-0.04%)
IONS : 30.08 (+0.23%)
Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Lags Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of -9.43% and -16.81%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

IONS : 30.08 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

See More

Key Turning Points

3rd Resistance Point 33.63
2nd Resistance Point 32.85
1st Resistance Point 31.43
Last Price 30.08
1st Support Level 29.23
2nd Support Level 28.44
3rd Support Level 27.02

See More

52-Week High 64.37
Fibonacci 61.8% 49.35
Fibonacci 50% 44.71
Fibonacci 38.2% 40.06
Last Price 30.08
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar